HIV genotypic resistance testing is a laboratory method used to identify genetic changes in the human immunodeficiency virus that may reduce the effectiveness of certain antiretroviral medicines. These changes, known as resistance mutations, can develop when the virus replicates and may affect how well specific treatments work. The test examines selected portions of the viral genetic material to identify mutations associated with resistance to HIV medications. Healthcare professionals use these results alongside treatment history, viral load measurements, and other clinical information to help select appropriate antiretroviral therapy.
HIV treatment has improved significantly with the development of antiretroviral therapy (ART), which suppresses viral replication and helps people maintain their health. However, HIV can develop genetic mutations that reduce its susceptibility to certain medicines. Genotypic resistance testing helps healthcare professionals identify these changes and understand which antiretroviral drugs may be less effective. The test is particularly useful when selecting an initial treatment regimen in appropriate clinical situations or investigating a detectable viral load during treatment.
Genotypic resistance testing analyzes the genetic material of HIV to identify mutations associated with resistance to antiretroviral medicines. The test commonly examines viral genes that contain information about enzymes targeted by HIV medications, including reverse transcriptase, protease, and integrase.
A blood sample is generally collected, and the laboratory analyzes the viral genetic material when sufficient HIV RNA is present. The results identify mutations that may influence how the virus responds to particular medications.
The testing process generally involves the following steps:
Sample collection: A blood sample is obtained to measure and analyze HIV genetic material.
Viral RNA analysis: The laboratory extracts viral RNA and uses molecular techniques to examine relevant genetic regions.
Genetic sequencing: Selected portions of the viral genome are sequenced to identify mutations.
Mutation interpretation: Identified genetic changes are compared with established resistance information to determine their potential clinical significance.
Clinical review: Healthcare professionals interpret the results alongside viral load measurements, medication history, and other relevant information.
Genotypic testing does not directly measure how effectively every medication will work in an individual. Instead, it identifies genetic changes known to be associated with reduced drug susceptibility. Some mutations have a strong association with resistance, while others may have a smaller or uncertain effect.
Resistance testing can help guide treatment decisions at different stages of HIV care. Its use depends on the person's treatment history, viral load, previous resistance results, and current clinical circumstances.
Healthcare professionals may consider testing in situations such as:
Before starting treatment: Baseline testing can identify transmitted resistance mutations that may affect the selection of an initial treatment regimen.
When treatment is not working as expected: If viral load remains detectable or rises during therapy, resistance testing may help investigate the cause.
After treatment changes: Previous resistance results can help inform decisions when modifying a treatment regimen.
During certain pregnancy-related situations: Testing may be recommended when resistance could affect treatment decisions during pregnancy.
When selecting future medications: Historical and current resistance information can help identify treatment options that are more likely to remain effective.
The test has limitations. It may not detect every resistant viral variant, particularly when the viral load is low or resistant variants are present in small proportions. Previous resistance mutations may also remain clinically relevant even if they are not detected in a later test. Therefore, historical results are important when evaluating treatment options.
HIV genotypic resistance testing is an important tool for understanding how viral genetic changes may influence antiretroviral treatment. By identifying resistance-associated mutations, it can help healthcare professionals make informed treatment decisions and investigate possible treatment failure. The results are most useful when interpreted alongside viral load measurements, medication history, adherence information, and clinical findings.